GAZYVARO 1000 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

( ARTG ) Chronic Lymphocytic Leukaemia,Gazyva in combination with chlorambucil is indicated for the treatment of patients with previously untreated chronic lymphocytic leukaemia (CLL).,Follicular Lymphoma,Gazyva in combination with chemotherapy followed by Gazyva maintenance is indicated for the treatment of patients with previously untreated advanced follicular lymphoma.,Gazyva in combination with bendamustine, followed by Gazyva maintenance, is indicated for the treatment of patients with follicular lymphoma (FL) who did not respond to, or who progressed during or up to 6 months after treatment with rituximab or a rituximab-containing regimen.,Pre-treatment to reduce the risk of Cytokine Release Syndrome (CRS) induced by glofitamab,Gazyva is indicated as a pre-treatment to reduce the risk of cytokine release syndrome (CRS) induced by glofitamab.